SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-103891
Filing Date
2020-04-10
Accepted
2020-04-10 16:35:57
Documents
4
Period of Report
2020-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d825760d8k.htm 8-K 52763
2 EX-3.1 d825760dex31.htm EX-3.1 36371
3 EX-4.1 d825760dex41.htm EX-4.1 430175
4 EX-99.1 d825760dex991.htm EX-99.1 10129
  Complete submission text file 0001193125-20-103891.txt   530714
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 20786998
SIC: 2834 Pharmaceutical Preparations